ArriVent BioPharma Inc. C... (AVBP)
NASDAQ: AVBP
· Real-Time Price · USD
19.54
0.92 (4.94%)
At close: Aug 15, 2025, 3:59 PM
19.58
0.20%
After-hours: Aug 15, 2025, 05:41 PM EDT
ArriVent BioPharma Common Stock Ratios and Metrics
Financials in USD. Fiscal
year is
undefined.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
PE Ratio | -6.07 | -2.43 | -10.84 | -9.59 | -6.95 | -8.8 | -7.9 | -11.63 | -7.77 | -13.76 | -16.04 | -14.23 | -0.87 | -0.87 |
PEG Ratio | 0.12 | -0.01 | n/a | 1.56 | -0.28 | 0.50 | -0.17 | 0.35 | -0.1 | -0.85 | 1.40 | 0.15 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 3.05 | 3.09 | 3.47 | 2.84 | 2.05 | 1.93 | 4.43 | 3.89 | 3.60 | 3.84 | 3.84 | n/a | n/a | 0.62 |
P/FCF Ratio | -29.17 | -9.22 | -55.39 | -48.28 | -31.86 | -32.92 | -44.92 | -43.38 | -77.84 | -39.68 | -42.16 | -67.49 | -2.86 | -2.86 |
P/OCF Ratio | -29.17 | -9.22 | -55.39 | -48.28 | -31.86 | -32.92 | -44.92 | -43.38 | -77.84 | -39.68 | -42.16 | -67.49 | -2.86 | -2.86 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | 0.00 | n/a | n/a | n/a |
Quick Ratio | 12.74 | 14.34 | 13.14 | 19.28 | 25.50 | 32.82 | 13.76 | 17.82 | 15.51 | n/a | 21.84 | n/a | n/a | n/a |
Current Ratio | 12.74 | 14.34 | 13.14 | 19.28 | 25.50 | 32.82 | 13.76 | 17.82 | 15.51 | n/a | 21.84 | n/a | n/a | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -0.13 | -0.32 | -0.08 | -0.07 | -0.07 | -0.05 | -0.14 | -0.08 | -0.12 | -0.07 | -0.06 | n/a | n/a | -0.18 |
Return on Assets | -0.12 | -0.3 | -0.08 | -0.07 | -0.07 | -0.05 | -0.13 | -0.08 | -0.11 | n/a | -0.06 | n/a | n/a | n/a |
Return on Invested Capital | -0.13 | -0.33 | -0.09 | -0.09 | -0.09 | -0.07 | -0.15 | -0.1 | -0.12 | n/a | -0.06 | n/a | n/a | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |